General Information of Drug Off-Target (DOT) (ID: OTXRU9XQ)

DOT Name Lipid droplet-associated hydrolase (LDAH)
Synonyms EC 3.1.1.-; Lipid droplet-associated serine hydrolase; hLDAH
Gene Name LDAH
Related Disease
Crohn disease ( )
Prostate carcinoma ( )
Sensorineural hearing loss disorder ( )
Ulcerative colitis ( )
Prostate cancer ( )
Prostate neoplasm ( )
UniProt ID
LDAH_HUMAN
3D Structure
Download
2D Sequence (FASTA)
Download
3D Structure (PDB)
Download
EC Number
3.1.1.-
Pfam ID
PF10230
Sequence
MDSELKEEIPVHEEFILCGGAETQVLKCGPWTDLFHDQSVKRPKLLIFIIPGNPGFSAFY
VPFAKALYSLTNRRFPVWTISHAGHALAPKDKKILTTSEDSNAQEIKDIYGLNGQIEHKL
AFLRTHVPKDMKLVLIGHSIGSYFTLQMLKRVPELPVIRAFLLFPTIERMSESPNGRIAT
PLLCWFRYVLYVTGYLLLKPCPETIKSLLIRRGLQVMNLENEFSPLNILEPFCLANAAYL
GGQEMMEVVKRDDETIKEHLCKLTFYYGTIDPWCPKEYYEDIKKDFPEGDIRLCEKNIPH
AFITHFNQEMADMIADSLKDDLSKM
Function
Probable serine lipid hydrolase associated with lipid droplets. Appears to lack cholesterol esterase activity. Appears to lack triglyceride lipase activity. Highly expressed in macrophage-rich areas in atherosclerotic lesions, suggesting that it could promote cholesterol ester turnover in macrophages.
Tissue Specificity Present in macrophage-rich areas in atherosclerotic lesionsv(at protein level).

Molecular Interaction Atlas (MIA) of This DOT

6 Disease(s) Related to This DOT
Disease Name Disease ID Evidence Level Mode of Inheritance REF
Crohn disease DIS2C5Q8 Strong Biomarker [1]
Prostate carcinoma DISMJPLE Strong Biomarker [2]
Sensorineural hearing loss disorder DISJV45Z Strong Genetic Variation [2]
Ulcerative colitis DIS8K27O Strong Biomarker [1]
Prostate cancer DISF190Y Limited Biomarker [2]
Prostate neoplasm DISHDKGQ Limited Biomarker [3]
------------------------------------------------------------------------------------
⏷ Show the Full List of 6 Disease(s)
Molecular Interaction Atlas (MIA) Jump to Detail Molecular Interaction Atlas of This DOT
7 Drug(s) Affected the Gene/Protein Processing of This DOT
Drug Name Drug ID Highest Status Interaction REF
Valproate DMCFE9I Approved Valproate affects the expression of Lipid droplet-associated hydrolase (LDAH). [4]
Ciclosporin DMAZJFX Approved Ciclosporin decreases the expression of Lipid droplet-associated hydrolase (LDAH). [5]
Cupric Sulfate DMP0NFQ Approved Cupric Sulfate decreases the expression of Lipid droplet-associated hydrolase (LDAH). [6]
Temozolomide DMKECZD Approved Temozolomide decreases the expression of Lipid droplet-associated hydrolase (LDAH). [7]
Hydrogen peroxide DM1NG5W Approved Hydrogen peroxide increases the expression of Lipid droplet-associated hydrolase (LDAH). [8]
Urethane DM7NSI0 Phase 4 Urethane decreases the expression of Lipid droplet-associated hydrolase (LDAH). [9]
GALLICACID DM6Y3A0 Investigative GALLICACID increases the expression of Lipid droplet-associated hydrolase (LDAH). [12]
------------------------------------------------------------------------------------
⏷ Show the Full List of 7 Drug(s)
2 Drug(s) Affected the Post-Translational Modifications of This DOT
Drug Name Drug ID Highest Status Interaction REF
Benzo(a)pyrene DMN7J43 Phase 1 Benzo(a)pyrene affects the methylation of Lipid droplet-associated hydrolase (LDAH). [10]
Bisphenol A DM2ZLD7 Investigative Bisphenol A decreases the methylation of Lipid droplet-associated hydrolase (LDAH). [11]
------------------------------------------------------------------------------------

References

1 Characterization of genetic loci that affect susceptibility to inflammatory bowel diseases in African Americans.Gastroenterology. 2015 Nov;149(6):1575-1586. doi: 10.1053/j.gastro.2015.07.065. Epub 2015 Aug 14.
2 Loss of LDAH associated with prostate cancer and hearing loss.Hum Mol Genet. 2018 Dec 15;27(24):4194-4203. doi: 10.1093/hmg/ddy310.
3 Genome-wide association study identifies five new susceptibility loci for prostate cancer in the Japanese population.Nat Genet. 2010 Sep;42(9):751-4. doi: 10.1038/ng.635. Epub 2010 Aug 1.
4 Gene Expression Regulation and Pathway Analysis After Valproic Acid and Carbamazepine Exposure in a Human Embryonic Stem Cell-Based Neurodevelopmental Toxicity Assay. Toxicol Sci. 2015 Aug;146(2):311-20. doi: 10.1093/toxsci/kfv094. Epub 2015 May 15.
5 Integrating multiple omics to unravel mechanisms of Cyclosporin A induced hepatotoxicity in vitro. Toxicol In Vitro. 2015 Apr;29(3):489-501.
6 Physiological and toxicological transcriptome changes in HepG2 cells exposed to copper. Physiol Genomics. 2009 Aug 7;38(3):386-401.
7 Temozolomide induces activation of Wnt/-catenin signaling in glioma cells via PI3K/Akt pathway: implications in glioma therapy. Cell Biol Toxicol. 2020 Jun;36(3):273-278. doi: 10.1007/s10565-019-09502-7. Epub 2019 Nov 22.
8 Oxidative stress modulates theophylline effects on steroid responsiveness. Biochem Biophys Res Commun. 2008 Dec 19;377(3):797-802.
9 Ethyl carbamate induces cell death through its effects on multiple metabolic pathways. Chem Biol Interact. 2017 Nov 1;277:21-32.
10 Air pollution and DNA methylation alterations in lung cancer: A systematic and comparative study. Oncotarget. 2017 Jan 3;8(1):1369-1391. doi: 10.18632/oncotarget.13622.
11 DNA methylome-wide alterations associated with estrogen receptor-dependent effects of bisphenols in breast cancer. Clin Epigenetics. 2019 Oct 10;11(1):138. doi: 10.1186/s13148-019-0725-y.
12 Gene expression profile analysis of gallic acid-induced cell death process. Sci Rep. 2021 Aug 18;11(1):16743. doi: 10.1038/s41598-021-96174-1.